Navigation Links
'Recovery coaches' effective in reducing number of babies exposed to drugs
Date:1/5/2009

About 11 percent of the 4 million babies born in the U.S. each year have been exposed to alcohol or illicit drugs in the womb, according to a June 2006 report by the National Center on Substance Abuse and Child Welfare. If removed from the home by child protection, these children tend to remain in foster care longer, and chances are very low that they will be reunited with their parents.

However, a groundbreaking study led by Joseph P. Ryan, a faculty member in the School of Social Work at the University of Illinois, indicates that recovery coaches can significantly reduce the number of substance-exposed births as well as help reunite substance-involved families, saving state child-welfare systems millions of dollars in foster-care and other placement costs.

The study, part of a larger collaboration among the U. of I., the Department of Children and Family Services, and Treatment Alternatives for Safe Communities, appeared in the journal Child Abuse and Neglect. The sample included 931 women in Chicago and suburban Cook County who had lost temporary custody of their children to DCFS, and who were chronic substance abusers referred for alcohol and drug assessments. Sixty-nine percent of the women had given birth to at least one substance-exposed infant prior to enrollment in the study.

Although several characteristics age, race, and cocaine or heroin use among them place certain women at higher risk for giving birth to a substance exposed infant, mothers who have at least one prior substance-exposed infant are significantly more likely to deliver additional substance-exposed infants.

The study made use of an experimental design: Families were randomly assigned to one of two treatment conditions. The mothers assigned to the control group during the five-year study received traditional child-welfare and substance-abuse services; the mothers assigned to the experimental group received traditional services plus the services of
'/>"/>

Contact: Sharita Forrest, News Editor
slforres@illinois.edu
217-244-1072
University of Illinois at Urbana-Champaign
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Addiction Recovery Program- Cares More About People than Profits, Providing a "Pay-What-You-Can" Option for January 2009
2. Marital Distress May Affect Breast Cancer Recovery
3. Coalition to Salute Americas Heroes(TM) Hosts Record Turnout of Wounded Veterans, Families for 2008 Road to Recovery Conference & Tribute
4. AARP: Health Care and Pension Reform Critical to Economic Recovery
5. Portable CT increases chance of stroke survival and recovery
6. When to Get Back Behind the Wheel While on the Road to Recovery
7. Governors, Legislators Update Current State Fiscal Conditions, Push for Economic Recovery Package from Congress, President-elect
8. Design Firm Taps Into Veterans Subconscious to Aid in Designing First-of-its- Kind Recovery Center
9. C.A.R.E. Florida Launches Family Weekends to Help on That Long Road to Recovery
10. Dual treatment for stroke leads to improved recovery rates, reduced mortality
11. Intelect Medical Closes $11 Million in Funding from Boston Scientific and Greatbatch for Stroke and TBI Recovery Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
'Recovery coaches' effective in reducing number of babies exposed to drugs
'Recovery coaches' effective in reducing number of babies exposed to drugs
(Date:7/3/2009)...ding will lead to treatments, , , FRIDA...y they,ve found a major cellular flaw that may dri...When caught early, lung cancer can often be treate...se is well advanced. Though doctors can sometimes ...prings back more virulent than ever, frequently sp...
(Date:7/3/2009)...ire-Asia/ -- Sundia MediTech, a leading,integrate...ompany in Shanghai,China announced today that Dr...ent of Chemistry Services. , Prior to joini...es, a drug,discovery and development company in S...t to Senior Director of Medicinal Chemistry of Neu...
(Date:7/3/2009)...panies and three individuals have been recognized ...tional competition designed to reward workplace he...tyXChange.org community released its 2009 Saxcies ...ww.safetyxchange.org/saxcies-video . The winners a...te their lives to keeping others safe - are detail...
(Date:7/3/2009)...Whitaker, MD, a founder of the alternative health ...ain.com, a new informational Web site devoted to a...tions. , Potomac, MD (Voc... of the alternative health movement, is now a feat...ional Web site devoted to all aspects of joint and...
Breaking Medicine News(10 mins):Health News:Cell Pathway May Be Key to Lung Cancer's Spread 2Health News:Cell Pathway May Be Key to Lung Cancer's Spread 3Health News:Sundia MediTech Appoints Dr. Chen Chen as Senior VP of Chemistry 2Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 2Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 3Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 4Health News:Dr. Julian Whitaker Featured on Searchjointpain.com 2
...of a recent study researchers say that the circadi...epeat in 24-hour cycles , can significantly impact...ercise // or receive medical treatments . During t...n 8:00 a.m. and 5:00 p.m were examined. Results f...
... the most common cancer among men, affecting about...d 220,000 new cases // of the disease are diagnose...te cancer every year. New research shows men who a...lining of their prostate ducts run a high risk of ...
...ws that people who suffer from sleep apnea run a h...sia administered // during surgery . Sleep apnea i...iodically during sleep . Statistics show the most ...obstructive sleep apnea, affects as many as 4 perc...
...a laugh signifies more than humor and ridicule, re...cal evidence // of the role of laughter during psy...e about communicating emotion than about humor. Re...s and took physiological measurements of both memb...
Other Medicine News:
(Date:6/29/2009)...and, June 29 Vantia Therapeutics, ...el, small molecule drugs,targeting large, underse...rom,a Phase IIa clinical trial of its lead develo...howed that oral VA106483 was successful in produci...ct in patients, as determined by,increased osmola...
(Date:6/26/2009)...ne 26 Sanofi-aventis (... aware of data associated with a retrospective fol...these data clearly show that no definitive conclus...tionship between Lantus(R) (insulin glargine [rDNA...s, as the authors of the study point out. , , C...
(Date:6/25/2009)...Newswire-USNewswire/ -- As of mid-2009, The Michae...lready funded over $1 million in high-risk, high-r...pment through its groundbreaking Rapid Response I... of the safety and efficacy of an FDA-approved dru...erization of a tenuous link between PD and certain...
(Date:6/24/2009)...June 25 , - Recru...r the,Non-Surgical Treatment of Eye Disease With ...V (Euronext Brussels: THR), a biotechnology compan...ovative treatments for eye,disease, vascular dise...uct,microplasmin, which is in Phase III trials fo...
Breaking Medicine Technology:Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 2Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 3Sanofi-aventis Stands Behind the Safety of Lantus(R) 2Sanofi-aventis Stands Behind the Safety of Lantus(R) 3MJFF's Rapid Response Innovation Awards Hit Mid-2009 With Over $1 Million Funded in High-Risk/High-Reward Approaches to Parkinson's Disease 2MJFF's Rapid Response Innovation Awards Hit Mid-2009 With Over $1 Million Funded in High-Risk/High-Reward Approaches to Parkinson's Disease 3ThromboGenics' Microplasmin Phase III Program Progressing According to Schedule 2ThromboGenics' Microplasmin Phase III Program Progressing According to Schedule 3Cascade of Studies New Clinical Tests Build the Case for Genetic Testing in Pharmacy Care Says Medco Expert 37918 1Cascade of Studies New Clinical Tests Build the Case for Genetic Testing in Pharmacy Care Says Medco Expert 37918 2Cascade of Studies New Clinical Tests Build the Case for Genetic Testing in Pharmacy Care Says Medco Expert 37918 3Cascade of Studies New Clinical Tests Build the Case for Genetic Testing in Pharmacy Care Says Medco Expert 37918 4Actuaries 3A Priority on Health Reform and Retirement Security Signals Tough Choices Ahead 37916 1Actuaries 3A Priority on Health Reform and Retirement Security Signals Tough Choices Ahead 37916 2Actuaries 3A Priority on Health Reform and Retirement Security Signals Tough Choices Ahead 37916 3AIDS Action Applauds President on Appointment of Jeffrey Crowley as Director of National AIDS Policy 37914 1AIDS Action Applauds President on Appointment of Jeffrey Crowley as Director of National AIDS Policy 37914 2Alzheimers Plaques More Complex Than Thought 37912 1Alzheimers Plaques More Complex Than Thought 37912 2
...2007 /PRNewswire-FirstCall/ --,Telik, Inc. announc... Phase 2 trial of the triplet combination of TELCY...paclitaxel will be,presented at the 98th annual me...rch (AACR) in Los Angeles. Preclinical studies of,...ancer cell growth,inhibition with TELCYTA in combi...
...2007 /PRNewswire-FirstCall/ --,Pharmacyclics, Inc....its novel histone deacetylase (HDAC) inhibitor and... presentations,will take place at the American Ass...eting being held April 14-18, 2007, at the Los,Ang... The presentations are as follows:, Sunday, A...
Other Medicine Technology:Telik Announces Telcyta Clinical and Preclinical Presentations at,AACR Meeting 2Telik Announces Telcyta Clinical and Preclinical Presentations at,AACR Meeting 3Pharmacyclics Announces Presentations on Its Novel and Selective,HDAC and Bruton's Tyrosine Kinase Inhibitor Compounds 2Pharmacyclics Announces Presentations on Its Novel and Selective,HDAC and Bruton's Tyrosine Kinase Inhibitor Compounds 3Pharmacyclics Announces Presentations on Its Novel and Selective,HDAC and Bruton's Tyrosine Kinase Inhibitor Compounds 4
Liquichek Hematology-8 Control is a whole blood hematology control with extended stability for non-differential analyzers.
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays.
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays.
Built on the market leading optical performance of the OMEGA 180, the OMEGA 500 has been optimized for even better views of the fundus. A new multi-coated illumination system, including a new XHL Xen
Medicine Products: